APA

Sewak S., Kosmider S., Ganju V., Woollett A., Yeow E. G., Le B., Henry M., Debrincat M. A. & Bell R. (20110118). Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting. : Internal medicine journal.

Chicago

Sewak S, Kosmider S, Ganju V, Woollett A, Yeow E G, Le B, Henry M, Debrincat M A and Bell R. 20110118. Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting. : Internal medicine journal.

Harvard

Sewak S., Kosmider S., Ganju V., Woollett A., Yeow E. G., Le B., Henry M., Debrincat M. A. and Bell R. (20110118). Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting. : Internal medicine journal.

MLA

Sewak S, Kosmider S, Ganju V, Woollett A, Yeow E G, Le B, Henry M, Debrincat M A and Bell R. Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting. : Internal medicine journal. 20110118.